The effects of membrane cholesterol and simvastatin on red blood cell deformability and ATP release.

[1]  Alison M. Forsyth,et al.  Multiscale approach to link red blood cell dynamics, shear viscosity, and ATP release , 2011, Proceedings of the National Academy of Sciences.

[2]  Alison M. Forsyth,et al.  The dynamic behavior of chemically "stiffened" red blood cells in microchannel flows. , 2010, Microvascular research.

[3]  Sukhen Das,et al.  Effect of some statin group of drugs on the phase profile of liposomal membrane – a fluorescence anisotropy study , 2009 .

[4]  I. Tentes,et al.  Statin Use is Associated with a Significant Reduction in Cholesterol Content of Erythrocyte Membranes. A Novel Pleiotropic Effect? , 2009, Cardiovascular Drugs and Therapy.

[5]  Christopher G Ellis,et al.  Erythrocytes: oxygen sensors and modulators of vascular tone. , 2009, Physiology.

[6]  Howard A Stone,et al.  Dynamics of shear-induced ATP release from red blood cells , 2008, Proceedings of the National Academy of Sciences.

[7]  D. Spence,et al.  Simultaneous determination of cell aging and ATP release from erythrocytes and its implications in type 2 diabetes. , 2008, Analytica chimica acta.

[8]  G. Kolovou,et al.  Simvastatin: two decades in a circle. , 2008, Cardiovascular therapeutics.

[9]  E. Solá,et al.  Erythrocyte membrane composition in patients with primary hypercholesterolemia. , 2008, Clinical hemorheology and microcirculation.

[10]  R. Virmani,et al.  Free cholesterol in atherosclerotic plaques: where does it come from? , 2007, Current opinion in lipidology.

[11]  J. Kaski,et al.  Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability? , 2007, Journal of the American College of Cardiology.

[12]  J. Westerweel,et al.  In vivo whole-field blood velocity measurement techniques , 2007 .

[13]  T. Steck,et al.  Scrambling of phospholipids activates red cell membrane cholesterol. , 2007, Biochemistry.

[14]  Howard A. Stone,et al.  Introduction to Fluid Dynamics for Microfluidic Flows , 2007 .

[15]  John M. Walker,et al.  Lipid Rafts , 2007, Methods in Molecular Biology.

[16]  F. Maxfield,et al.  Role of cholesterol and lipid organization in disease , 2005, Nature.

[17]  E. Feigl,et al.  Plasma ATP during exercise: possible role in regulation of coronary blood flow. , 2005, American journal of physiology. Heart and circulatory physiology.

[18]  M. Zuckermann,et al.  What's so special about cholesterol? , 2004, Lipids.

[19]  T. Steck,et al.  How cholesterol homeostasis is regulated by plasma membrane cholesterol in excess of phospholipids. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Munro Lipid Rafts Elusive or Illusive? , 2003, Cell.

[21]  M. Cassera,et al.  Differential effects of cholesterol on acyl chain order in erythrocyte membranes as a function of depth from the surface. An electron paramagnetic resonance (EPR) spin label study. , 2002, Biophysical chemistry.

[22]  J. Clancy,et al.  Cystic Fibrosis Transmembrane Conductance Regulator Facilitates ATP Release by Stimulating a Separate ATP Release Channel for Autocrine Control of Cell Volume Regulation* , 2001, The Journal of Biological Chemistry.

[23]  H. Mcconnell,et al.  Condensed complexes, rafts, and the chemical activity of cholesterol in membranes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  I. Levitan,et al.  Membrane Cholesterol Content Modulates Activation of Volume-Regulated Anion Current in Bovine Endothelial Cells , 2000, The Journal of general physiology.

[25]  F. Kuralay,et al.  Effect of simvastatin therapy on blood and tissue ATP levels and erythrocyte membrane lipid composition. , 2000, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[26]  D. M. Amundson,et al.  Fluorometric method for the enzymatic determination of cholesterol. , 1999, Journal of biochemical and biophysical methods.

[27]  M. L. Ellsworth,et al.  Deformation-induced ATP release from red blood cells requires CFTR activity. , 1998, American journal of physiology. Heart and circulatory physiology.

[28]  R. Puniyani,et al.  The diagnostic relevance of red cell rigidity. , 1998, Clinical hemorheology and microcirculation.

[29]  M C Phillips,et al.  Use of cyclodextrins for manipulating cellular cholesterol content. , 1997, Journal of lipid research.

[30]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[31]  D. Mitov,et al.  Bending elasticities of model membranes: influences of temperature and sterol content. , 1997, Biophysical journal.

[32]  J. Yoshikawa,et al.  Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients. , 1997, Metabolism: clinical and experimental.

[33]  N. Weintraub,et al.  Erratum: Effect of L-NAME on pressure-flow relationships in isolated rabbit lungs: Role of red blood cells (American Journal of Physiology - Heart and Circulatory Physiology (December 1995) 269 (H1941-H1948)) , 1996 .

[34]  N. Weintraub,et al.  Effect of L-NAME on pressure-flow relationships in isolated rabbit lungs: role of red blood cells. , 1995, The American journal of physiology.

[35]  E. Evans,et al.  Structure and deformation properties of red blood cells: concepts and quantitative methods. , 1989, Methods in enzymology.

[36]  R M Hochmuth,et al.  Erythrocyte membrane elasticity and viscosity. , 1987, Annual review of physiology.

[37]  A Chabanel,et al.  Influence of cholesterol content on red cell membrane viscoelasticity and fluidity. , 1983, Biophysical journal.

[38]  H. G. Rose,et al.  IMPROVED PROCEDURE FOR THE EXTRACTION OF LIPIDS FROM HUMAN ERYTHROCYTES. , 1965, Journal of lipid research.